Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionLarson Financial Group LLC
Latest Disclosed Ownership12,065 shares
Latest Disclosed Value $ 1,681,487
Larson Financial Group LLC reports 28.34% increase in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - Larson Financial Group LLC filed a 13F-HR form disclosing ownership of 12,065 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,681,487 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 9,401 shares of Gilead Sciences, Inc.. This represents a change in shares of 28.34% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 12,065 2,664 28.34 1,681 45.79 0.0504
2026-02-06 2025-12-31 13F GILEAD SCIENCES COM 375558103 9,401 1,088 13.09 1,154 25.05 0.0384
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 8,313 -4,859 -36.89 923 -36.85 0.0323
2025-08-08 2025-06-30 13F GILEAD SCIENCES COM 375558103 13,172 1,696 14.78 1,460 13.62 0.0585
2025-05-02 2025-03-31 13F GILEAD SCIENCES COM 375558103 11,476 2,271 24.67 1,286 51.18 0.0609
2025-02-07 2024-12-31 13F GILEAD SCIENCES COM 375558103 9,205 1,370 17.49 850 29.57 0.0439
2024-11-12 2024-09-30 13F GILEAD SCIENCES COM 375558103 7,835 3,464 79.25 657 119.40 0.0373
2024-08-02 2024-06-30 13F GILEAD SCIENCES COM 375558103 4,371 2,878 192.77 300 174.31 0.0204
2024-05-03 2024-03-31 13F GILEAD SCIENCES COM 375558103 1,493 276 22.68 109 11.22 0.0085
2024-02-01 2023-12-31 13F GILEAD SCIENCES COM 375558103 1,217 18 1.50 99 10.11 0.0086
2023-11-03 2023-09-30 13F GILEAD SCIENCES COM 375558103 1,199 156 14.96 90 11.25 0.0088
2023-08-03 2023-06-30 13F GILEAD SCIENCES COM 375558103 1,043 84 8.76 80 1.27 0.0080
2023-05-04 2023-03-31 13F GILEAD SCIENCES COM 375558103 959 -163 -14.53 80 -17.71 0.0086
2023-02-03 2022-12-31 13F GILEAD SCIENCES COM 375558103 1,122 233 26.21 96 74.55 0.0115
2022-11-03 2022-09-30 13F GILEAD SCIENCES COM 375558103 889 60 7.24 55 7.84 0.0078
2022-08-04 2022-06-30 13F GILEAD SCIENCES COM 375558103 829 15 1.84 51 6.25 0.0088
2022-05-05 2022-03-31 13F GILEAD SCIENCES COM 375558103 814 9 1.12 48 -17.24 0.0077
2022-02-03 2021-12-31 13F GILEAD SCIENCES COM 375558103 805 -79 -8.94 58 -6.45 0.0092
2021-11-04 2021-09-30 13F GILEAD SCIENCES COM 375558103 884 -162 -15.49 62 -13.89 0.0123
2021-08-10 2021-06-30 13F GILEAD SCIENCES COM 375558103 1,046 161 18.19 72 26.32 0.0167
2021-05-06 2021-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 885 178 25.18 57 39.02 0.0168
2021-04-08 2021-03-31 13F GILEAD SCIENCES COM 375558103 707 0 41 0.0140
2021-01-14 2020-12-31 13F GILEAD SCIENCES COM 375558103 707 9 1.29 41 -6.82 0.0139
2020-10-08 2020-09-30 13F GILEAD SCIENCES COM 375558103 698 2 0.29 44 -18.52 0.0181
2020-07-10 2020-06-30 13F GILEAD SCIENCES COM 375558103 696 -87 -11.11 54 -8.47 0.0257
2020-04-09 2020-03-31 13F GILEAD SCIENCES COM 375558103 783 148 23.31 59 43.90 0.0369
2020-01-10 2019-12-31 13F GILEAD SCIENCES COM 375558103 635 -191 -23.12 41 -21.15 0.0236
2019-10-11 2019-09-30 13F GILEAD SCIENCES COM 375558103 826 194 30.70 52 20.93 0.0340
2019-07-16 2019-06-30 13F GILEAD SCIENCES COM 375558103 632 13 2.10 43 7.50 0.0319
2019-04-05 2019-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 619 6 0.98 40 5.26 0.0317
2019-04-04 2019-03-31 13F GILEAD SCIENCES COM 375558103 613 0 38 0.0351
2019-02-07 2018-12-31 13F GILEAD SCIENCES COM 375558103 613 613 38 0.0351
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.